Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | BCAB BioAtla, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.71 -10.0% | $15.06 -2.0% |
| StockIQ Score | 46D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 30F | 13F |
| Fundamental | 25F | 35F |
| Growth | 63C+ | 50C- |
| Fair Value | 55C | 38F |
| News | 80A- | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 32F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
BioAtla (BCAB) outperforms Ascentage Pharma (AAPG) in growth and valuation, scoring 63 and 50 respectively, compared to AAPG’s 50 and 38. However, AAPG has a slightly better investor score (37 vs. 42) and higher technical score (18 vs. 6). Both carry a "WEAK" rating, but BCAB’s stronger growth and valuation scores make it the more favorable in those areas.
